AN Ventures is a venture capital fund focused on building blockbuster biotech companies by leveraging scientific innovations from Japan. The firm aims to maximize value creation by establishing companies within the top global biotech ecosystem, syndicating with leading global venture investors to enhance success and visibility for Japanese science. With a strong team of experienced healthcare investors and entrepreneurs, AN Ventures is positioned to capitalize on significant scientific arbitrage opportunities in the biotech sector, driving advancements in life sciences and addressing unmet medical needs.
Investment focus
Investment style
Specialist
Latest fund size
$200 million
Latest fund vintage
2025
Data last enriched
Aug 14, 2026
Investing team
- Ken HorneManaging Partner
- Ari NowacekPartner
- Takashi FutamiPartner
- Jun HashimotoPartner
- Toshikazu BanExecutive Partner
- Atsushi ShimadaVenture Partner
- Masaki TanakaInvestment Manager
- Paula SchultheissSenior Associate
- Dai HataAssociate
- Shiho HiroseAnalyst